Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN).

Saved in:
Bibliographic Details
Title: Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN).
Authors: Takeshita N; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan; Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan., Enokida T; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Okano S; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Fujisawa T; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Wada A; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan; Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Sato M; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan; Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Tanaka H; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Tanaka N; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Onaga R; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Hoshi Y; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Sakashita S; Department of Pathology and Laboratory Medicine, National Cancer Center Hospital East, Kashiwa, Japan., Ishii G; Department of Pathology and Laboratory Medicine, National Cancer Center Hospital East, Kashiwa, Japan., Tahara M; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan. Electronic address: matahara@east.ncc.go.jp.
Source: Oral oncology [Oral Oncol] 2023 Dec; Vol. 147, pp. 106615. Date of Electronic Publication: 2023 Nov 04.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0593
DOI:10.1016/j.oraloncology.2023.106615